Annual report pursuant to Section 13 and 15(d)

Accrued expenses

v3.21.1
Accrued expenses
12 Months Ended
Dec. 31, 2020
Accrued expenses  
Accrued expenses

8.        Accrued Expenses

Accrued expenses consist of the following at:

 

 

 

 

 

 

 

 

 

 

December 31, 

 

December 31, 

 

    

2020

    

2019

Accrued preclinical and clinical trial expenses

 

$

628,000

 

$

1,156,618

Accrued manufacturing expenses

 

 

175,089

 

 

 —

Compensation and related benefits

 

 

209,600

 

 

303,870

Accrued franchise tax

 

 

172,500

 

 

 —

Other expenses

 

 

429,345

 

 

215,979

 

 

$

1,614,534

 

$

1,676,467